Relapsing Multiple Sclerosis (RMS)
Also known as: Multiple Sclerosis, Relapsing / Relapsing multiple sclerosis (MS) / Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00242 | Cladribine | A purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs. |
| DB00111 | Daclizumab | A monoclonal anti-CD25 antibody that blocks the interleukin-2 receptor which is used to treat relapsing forms of multiple sclerosis. |
| DB14783 | Diroximel fumarate | A drug used for the treatment of relapsing forms of Multiple Sclerosis (MS). |
| DB08868 | Fingolimod | A sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19. |
| DB00060 | Interferon beta-1a | A form of recombinant human interferon used to slow disease progression and reduce the frequency of clinical symptoms in patients who have relapsing multiple sclerosis. |
| DB00068 | Interferon beta-1b | A form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms. |
| DB11988 | Ocrelizumab | A CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis. |
| DB06650 | Ofatumumab | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. |
| DB09122 | Peginterferon beta-1a | An interferon beta used to treat relapsing forms of multiple sclerosis. |
| DB12016 | Ponesimod | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. |
| DB12371 | Siponimod | A medication used to treat relapsing multiple sclerosis. |